In June 2017, the European Commission adopted the EU One Health Action Plan against AMR. The key objectives of this plan are built on 3 main pillars:

  1. Making the EU a best practice region
  2. Boosting research, development and innovation
  3. Shaping the global agenda

The Commission has also adopted the first deliverables of the plan, for example the EU Guidelines on the prudent use of antimicrobials in human health. This complements the EU Guidelines on the prudent use of antimicrobials in animal health.

Since the implementation of the 2017 AMR EU Action Plan, important updates have been made in order to further strengthen EU’s response to AMR, for example the adoption of the Pharmaceutical Strategy for Europe (that will address several AMR challenges including the lack of investment in antimicrobials and inappropriate use of antibiotics), and the new Commission Implementing Decision (EU) 2020/1729 on the monitoring and reporting of antimicrobial resistance in zoonotic and commensal bacteria. This Decision is based on the latest scientific opinions and addresses known implementation issues while scientifically responding and ensuring continuity in assessing future trends in AMR.

More information and latest updates on the topic can be fund at this link.